Nalaganje...
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine
Histone deacetylase inhibitors (HDACis) have emerged as a new class of anticancer agents, targeting the biological process including cell cycle and apoptosis. We investigated and explained the anticancer effects of an HDAC6 inhibitor, ricolinostat alone and in combination with bendamustine in lympho...
Shranjeno v:
| izdano v: | Apoptosis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401712/ https://ncbi.nlm.nih.gov/pubmed/28315173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10495-017-1364-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|